Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,371 public trials 203 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Recruiting

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT07225439

Conditions
B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
Locations
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
View Trial Details
Recruiting

Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

NCT05929222

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico Sassuolo, Modena (MO), Italy
  • Azienda Ospedaliera Nazionale Ss Antonio E Biagio E C Arrigo, SCDU Ematologia Alessandria, Italy
  • AORN San Giuseppe Moscati Avellino, U.O.C. Ematologia e Trapianto Emopoietico Avellino, Italy
  • Centro Di Riferimento Oncologico Di Aviano, S.O.C. Oncologia Medica e dei Tumori Immunocorrelati Aviano, Italy
View all 49 locations
View Trial Details
Recruiting

Mindfulness-Based Cognitive Therapy (MBCT) for the Prevention of Depression Relapse or Recurrence Using Videoconference

NCT06832605

Conditions
Behavior, Behavioral Symptoms, Depression, +21 more
Locations
  • Parc de Salut Mar Barcelona, Spain
  • Parc Sanitari Sant Joan de Déu (PSSJD) Sant Boi de Llobregat, Barcelona, Spain
  • Hospital Universitario Miguel Servet Zaragoza, Spain
  • Hospital General Universitario de Elche Elche, Alicante, Spain
View Trial Details
Recruiting

Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)

NCT07083154

Conditions
Brain Diseases, Central Nervous System Diseases, Cognition Disorders, +24 more
Locations
  • Department of Endocrinology, Xiangya Hospital of Central South University Changsha, Hunan, China
  • Department of Endocrinology, Changzhou No.2 People's Hospital Changzhou, Jiangsu, China
  • Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University Nanjing, Jiangsu, China
  • Department of Endocrinology, Endocrine and Metabolic Disease Medical Center,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing, Jiangsu, China
View Trial Details
Recruiting

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

NCT07154823

Conditions
Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL), Hematologic Diseases, +15 more
Locations
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
  • The Center for Cancer and Blood Disorders Bethesda, Maryland, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • Cancer Care Specialists of Reno Reno, Nevada, United States
View Trial Details
Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

NCT06860594

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, Grade 2, Glioblastoma, +22 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 43 locations
View Trial Details
Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

NCT07215910

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, Grade 3, Glioma, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 121 locations
View Trial Details

Related conditions